C.F.R. » Title 21 » CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES › SUBCHAPTER F—BIOLOGICS › PART 610—GENERAL BIOLOGICAL PRODUCTS STANDARDS › Subpart B—General Provisions

21 C.F.R. § 610.9

Equivalent methods and processes

Read at: eCFRecfr.gov CornellLII GovInfogovinfo.gov CasesGoogle Scholar

Modification of any particular test method or manufacturing process or the conditions under which it is conducted as required in this part or in the additional standards for specific biological products in parts 620 through 680 of this chapter shall be permitted only under the following conditions:

(a) The applicant presents evidence, in the form of a license application, or a supplement to the application submitted in accordance with § 601.12(b) or (c), demonstrating that the modification will provide assurances of the safety, purity, potency, and effectiveness of the biological product equal to or greater than the assurances provided by the method or process specified in the general standards or additional standards for the biological product; and

(b) Approval of the modification is received in writing from the Director, Center for Biologics Evaluation and Research or the Director, Center for Drug Evaluation and Research.

[62 FR 39903, July 24, 1997, as amended at 70 FR 14984, Mar. 24, 2005]
Notes of Decisions
Cited in 1 case, 1990–1990 · leading case: In Re Sabin Oral Polio Vaccine Prods. Liab. Litig., 743 F. Supp. 410 (D. Maryland 1990).
Sort: Relevance Newest Treatment
In Re Sabin Oral Polio Vaccine Prods. Liab. Litig., 743 F. Supp. 410 (D. Maryland 1990). “Parts 610-680 into one section, 21 C.F.R. § 610.9 . See 49 Fed.Reg. 15186-87 (1984).”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.